Sijmen de Vries
Chief Executive Officer presso PHARMING GROUP N.V.
Patrimonio netto: 10 M $ in data 29/02/2024
Profilo
Currently, Sijmen de Vries occupies the position of Chief Executive Officer & Executive Director at Pharming Group NV and Chief Executive Officer for Pharming Intellectual Property BV (a subsidiary of Pharming Group NV).
He is also on the board of Sylus Pharmaceuticals Ltd.
and Biodexa Pharmaceuticals Plc and Finish Partner at BioConnection BV.
He previously occupied the position of Chief Executive Officer for Morphochem AG and Chief Executive Officer of 4-Antibody AG.
He received an MBA from Ashridge Business School and a doctorate from the University of Amsterdam.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
PHARMING GROUP NV
1.27% | 15/03/2024 | 8 544 736 ( 1.27% ) | 10 M $ | 29/02/2024 |
17/04/2023 | 1 322 ( 0.00% ) | 0 $ | 31/01/2024 |
Posizioni attive di Sijmen de Vries
Società | Posizione | Inizio |
---|---|---|
PHARMING GROUP N.V. | Chief Executive Officer | 13/10/2008 |
BIODEXA PHARMACEUTICALS PLC | Director/Board Member | 29/10/2014 |
Sylus Pharmaceuticals Ltd. | Director/Board Member | 21/06/2010 |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The private company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Chief Executive Officer | - |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands. | Corporate Officer/Principal | - |
Precedenti posizioni note di Sijmen de Vries
Società | Posizione | Fine |
---|---|---|
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 13/03/2015 |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Chief Executive Officer | - |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Morphochem AG discovers and develops drugs. It focuses on finding therapeutic agents to treat cancer, anti-infectives, inflammation, metabolic disorders and infectious diseases, with particular emphasis on enzyme inhibitors. The company has developed an integrated chemical genomics drug discovery engine that it is applying in third party research programs and for building its own fully owned pipeline. Morphochem is headquartered in Munich, Germany. | Chief Executive Officer | - |
Formazione di Sijmen de Vries
University of Amsterdam | Doctorate Degree |
Ashridge Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
PHARMING GROUP N.V. | Health Technology |
BIODEXA PHARMACEUTICALS PLC | Health Technology |
Aziende private | 6 |
---|---|
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Morphochem AG discovers and develops drugs. It focuses on finding therapeutic agents to treat cancer, anti-infectives, inflammation, metabolic disorders and infectious diseases, with particular emphasis on enzyme inhibitors. The company has developed an integrated chemical genomics drug discovery engine that it is applying in third party research programs and for building its own fully owned pipeline. Morphochem is headquartered in Munich, Germany. | Commercial Services |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands. | Health Technology |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Health Technology |
Sylus Pharmaceuticals Ltd. | |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The private company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Producer Manufacturing |